More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...

Eli Lilly's popular weight-loss drug Zepbound outperformed Danish drugmaker Novo Nordisk's Wegovy in a clinical trial, ...

Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid, and the director of WVU Medicine’s medical weight ...

As the Biden administration is proposing drugs like Ozempic and Wegovy be covered by Medicare and Medicaid, Black people need ...

West Virginia’s Public Employee Insurance Agency (PEIA) is in a bind.  Medical inflation continues to drive up health care costs and the PEIA finance board is looking for ways to save money while ...

Though some doctors have been trying to classify “obesity” as a “chronic illness,” being fat and being ill aren’t the same ...

A new rule the Biden administration has proposed that would let Americans with Medicare and Medicaid access Ozempic, Wegovy ...

After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets ...

More than 7 million Americans struggling with obesity would become eligible for coverage under the proposed change. (HealthDay News) — The Biden administration is proposing Medicare and Medicaid ...